ACE2-independent alternative receptors for SARS-CoV-2
S Lim, M Zhang, TL Chang - Viruses, 2022 - mdpi.com
Severe acute respiratory syndrome-related coronavirus (SARS-CoV-2), the causative agent
of coronavirus disease 2019 (COVID-19), is highly contagious and remains a major public …
of coronavirus disease 2019 (COVID-19), is highly contagious and remains a major public …
[HTML][HTML] Targeting phosphatidylserine for Cancer therapy: prospects and challenges
W Chang, H Fa, D Xiao, J Wang - Theranostics, 2020 - ncbi.nlm.nih.gov
Cancer is a leading cause of mortality and morbidity worldwide. Despite major
improvements in current therapeutic methods, ideal therapeutic strategies for improved …
improvements in current therapeutic methods, ideal therapeutic strategies for improved …
A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications
GW Wright, JD Phelan, ZA Coulibaly, S Roulland… - Cancer cell, 2020 - cell.com
The development of precision medicine approaches for diffuse large B cell lymphoma
(DLBCL) is confounded by its pronounced genetic, phenotypic, and clinical heterogeneity …
(DLBCL) is confounded by its pronounced genetic, phenotypic, and clinical heterogeneity …
The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma
Biological heterogeneity in diffuse large B cell lymphoma (DLBCL) is partly driven by cell-of-
origin subtypes and associated genomic lesions, but also by diverse cell types and cell …
origin subtypes and associated genomic lesions, but also by diverse cell types and cell …
[HTML][HTML] Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas
Most relapsed/refractory large B cell lymphoma (r/rLBCL) patients receiving anti-CD19
chimeric antigen receptor (CAR19) T cells relapse. To characterize determinants of …
chimeric antigen receptor (CAR19) T cells relapse. To characterize determinants of …
Genetic and phenotypic attributes of splenic marginal zone lymphoma
F Bonfiglio, A Bruscaggin, F Guidetti… - Blood, The Journal …, 2022 - ashpublications.org
Splenic marginal zone B-cell lymphoma (SMZL) is a heterogeneous clinico-biological entity.
The clinical course is variable, multiple genes are mutated with no unifying mechanism, and …
The clinical course is variable, multiple genes are mutated with no unifying mechanism, and …
The CD47-SIRPα axis is a promising target for cancer immunotherapies
Y Hao, X Zhou, Y Li, B Li, L Cheng - International Immunopharmacology, 2023 - Elsevier
Abstract Cluster of differentiation 47 (CD47) is a transmembrane protein that is ubiquitously
found on the surface of many cells in the body and uniquely overexpressed by both solid …
found on the surface of many cells in the body and uniquely overexpressed by both solid …
Toward a new molecular taxonomy of diffuse large B-cell lymphoma
Diffuse large B-cell lymphoma (DLBCL) represents a grouping of clinically and biologically
heterogeneous tumors. Application of advanced molecular technology has significantly …
heterogeneous tumors. Application of advanced molecular technology has significantly …
The role of CD47-SIRPα immune checkpoint in tumor immune evasion and innate immunotherapy
Z Li, Y Li, J Gao, Y Fu, P Hua, Y Jing, M Cai, H Wang… - Life Sciences, 2021 - Elsevier
As a transmembrane protein, CD47 plays an important role in mediating cell proliferation,
migration, phagocytosis, apoptosis, immune homeostasis, inhibition of NO signal …
migration, phagocytosis, apoptosis, immune homeostasis, inhibition of NO signal …